Patents by Inventor Fred L. Homa

Fred L. Homa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating herpes viruses
    Publication number: 20040115623
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Application
    Filed: October 24, 2003
    Publication date: June 17, 2004
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Method for treating herpes viruses
    Patent number: 6682892
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment. The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: January 27, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Method for treating herpes viruses
    Publication number: 20020076789
    Abstract: The present invention relates to a method for selecting an anti-herpes viral compound and a method for selectively inhibiting herpesvrus in a human host in need of such treatment.
    Type: Application
    Filed: July 12, 2001
    Publication date: June 20, 2002
    Inventors: Fred L. Homa, Michael W. Wathen, Todd A. Hopkins, Darrell R. Thomsen
  • Polyaromatic antiviral compositions
    Patent number: 6147116
    Abstract: The present invention relates to polyaromatic compounds having useful antiviral activity against viruses of the herpes family, to a composition containing them, and to a method of using them for the treatment of herpes viruses infections.
    Type: Grant
    Filed: May 11, 1999
    Date of Patent: November 14, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael Robert Barbachyn, Fred L. Homa, Antonio Monge, Esteban Santiago, Juan J. Martinez-Irujo, Maria Font
  • Cloned DNA encoding a UDP-GalNAc: Polypeptide, N-acetylgalactosaminyltransferase
    Patent number: 6096512
    Abstract: The present invention relates to a method for the isolation and expression of a glycosyltransferase enzyme for use in the synthesis of oligosaccharide or polysaccharide structures on glycoproteins, glycolipids, or as free molecules. The gene coding for the enzyme N-acetylgalactosaminyltransferase and the polypeptide sequence of the acceptor peptide for the enzyme N-acetylgalactosaminyltransferase have been isolated and used for the control of glycosylation of a protein.
    Type: Grant
    Filed: November 11, 1997
    Date of Patent: August 1, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Ake P. Elhammer, Fred L. Homa
  • Polyaromatic antiviral compositions
    Patent number: 5958983
    Abstract: The present invention relates to polyaromatic compounds having useful antiviral activity against viruses of the herpes family, to a composition containing them, and to a method of using them for the treatment of herpes viruses infections.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: September 28, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Michael R. Barbachyn, Fred L. Homa, Antonio Monge, Esteban Santiago, Juan J. Martinez-Irujo, Maria Font
  • Cloned DNA encoding a UDP-GalNAc: polypeptide N-acetylgalactosaminy-ltransferase
    Patent number: 5910570
    Abstract: The present invention relates to a method for the isolation and expression of a glycosyltransferase enzyme for use in the synthesis of oligosaccharide or polysaccharide structures on glycoproteins, glycolipids, or as free molecules. The gene coding for the enzyme N-acetylgalactosaminyltransferase and the polypeptide sequence of the acceptor peptide for the enzyme N-acetylgalactosaminyltransferase have been isolated and used for the control of glycosylation of a protein.
    Type: Grant
    Filed: November 11, 1997
    Date of Patent: June 8, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Ake P. Elhammer, Fred L. Homa